Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM)

Clinical Immunology

Volumn 152, Issue 1-2, 2014, Pages 36-47

  Dagur, Pradeep K ^a   Biancotto, Angélique ^b   Stansky, Elena ^a   Sen, H Nida ^c   Nussenblatt, Robert B ^b,c   McCoy, J Philip ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

CD146 MCAM; Class I antigen; Inflammation; Tc17

Indexed keywords

CD146 ANTIGEN; GRANZYME B; HLA ANTIGEN CLASS 1; INTERLEUKIN 17; PERFORIN;

ANTIGEN EXPRESSION; ARTICLE; BEHCET DISEASE; CD8+ T LYMPHOCYTE; CHORIORETINOPATHY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; UVEITIS;

CD146/MCAM; CLASS I ANTIGEN; INFLAMMATION; TC17;

ANTIGENS, CD146; BEHCET SYNDROME; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHORIORETINITIS; FEMALE; HUMANS; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; SARCOIDOSIS;

EID: 84897010288     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.01.009     Document Type: Article

References (30)

1. Hu Y., Shen F., Crellin N.K., Ouyang W. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Ann. N. Y. Acad. Sci. 2011, 1217:60-76.
2. Maddur M.S., Miossec P., Kaveri S.V., Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 2012, 181:8-18.
3. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
4. Huber M., Heink S., Grothe H., Guralnik A., Reinhard K., Elflein K., Hünig T., Mittrücker H.W., Brüstle A., Kamradt T., Lohoff M. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 2009, 39:1716-1725.
5. Yen H.R., Harris T.J., Wada S., Grosso J.F., Getnet D., Goldberg M.V., Liang K.L., Bruno T.C., Pyle K.J., Chan S.L., Anders R.A., Trimble C.L., Adler A.J., Lin T.Y., Pardoll D.M., Huang C.T., Drake C.G. Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 2009, 183:7161-7168.
6. Kondo T., Takata H., Matsuki F., Takiguchi M. Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J. Immunol. 2009, 182:1794-1798.
7. He D., Wu L., Kim H.K., Li H., Elmets C.A., Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 2006, 177:6852-6858.
8. Res P.C.M., Piskin G., de Boer O.J., van der Loos C.M., Teeling P., et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 2010, 5:e14108.
9. Annibali V., Ristori G., Angelini D.F., Serafini B., Mechelli R., Cannoni S., Romano S., Paolillo A., Abderrahim H., Diamantini A., Borsellino G., Aloisi F., Battistini L., Salvetti M. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain 2011, 134:542-554.
10. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 2007, 19:281-286.
11. Chen Z., O'Shea J.J. Regulation of IL-17 production in human lymphocytes. Cytokine 2008, 41:71-78.
12. Maggi L., Santarlasci V., Capone M., Peired A., Frosali F., Crome S.Q., Querci V., Fambrini M., Liotta F., Levings M.K., Maggi E., Cosmi L., Romagnani S., Annunziato F. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 2010, 40:2174-2181.
13. Li L., Yang X., Chen B.P.W., Struss P.E., Perna A., Wei B.Y., Jiang N., Kraft B., Lay G. Immunophenotypic characterization of Th17 cells in human peripheral blood. J. Immunol. 2009, 182:137.
14. Singh S.P., Zhang H.H., Foley J.F., Hedrick M.N., Farber J.M. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 2008, 180:214-221.
15. Bengsch B., Seigel B., Flecken T., Wolanski J., Blum H.E., Thimme R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). Immunol. 2012, 188:5438-5447.
16. Dagur P.K., Biancotto A., Wei L., Sen H.N., Yao M., Strober W., Nussenblatt R.B., McCoy J.P. MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J. Autoimmun. 2011, 37:319-327.
17. Larochelle C., Cayrol R., Kebir H., Alvarez J.I., Lécuyer M.A., Ifergan I., Viel É., Bourbonnière L., Beauseigle D., Terouz S., Hachehouche L., Gendron S., Poirier J., Jobin C., Duquette P., Flanagan K., Yednock T., Arbour N., Prat A. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 2012, 135:2906-2924.
18. Kamiyama T., Watanabe H., Iijima M., Miyazaki A., Iwamoto S. Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T-helper 17 cells. J. Dermatol. 2012, 39:838-842.
19. Bardin N., Anfosso F., Masse J.M., Cramer E., Sabatier F., Le Bivic A., Sampol J., Dignat-George F. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001, 98:3677-3684.
20. Elshal M.F., Khan S.S., Raghavachari N., Takahashi Y., Barb J., Bailey J.J., Munson P.J., Solomon M.A., Danner R.L., McCoy J.P. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol. 2007, 13:29.
21. Guezguez B., Vigneron P., Lamerant N., Kieda C., Jaffredo T., Dunon D. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J. Immunol. 2007, 179:6673-6685.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
23. Piga M., Mathieu A. Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford) 2011, 50:299-310.
24. Hughes T., Coit P., Adler A., Yilmaz V., Aksu K., Düzgün N., Keser G., Cefle A., Yazici A., Ergen A., Alpsoy E., Salvarani C., Casali B., Kötter I., Gutierrez-Achury J., Wijmenga C., Direskeneli H., Saruhan-Direskeneli G., Sawalha A.H. Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat. Genet. 2013, 45:319-324.
25. Brézin A.P., Monnet D., Cohen J.H., Levinson R.D. HLA-A29 and birdshot chorioretinopathy. Ocul. Immunol. Inflamm. 2011, 19:397-400.
26. de Waal L.P., Lardy N.M., van der Horst A.R., Baarsma G.S., Kijlstra A., Noens L., Priem H.A. HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics 1992, 35:51-53.
27. Morgenthau A.S., Iannuzzi M.C. Recent advances in sarcoidosis. Chest 2011, 139:174-182.
28. Sato H., Grutters J.C., Pantelidis P., Mizzon A.N., Ahmad T., Van Houte A.J., Lammers J.W., Van Den Bosch J.M., Welsh K.I., Du Bois R.M. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 2002, 27:406-412.
29. Vasilopoulos Y., Sagoo G.S., Cork M.J., Walters K., Tazi-Ahnini R. HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction. J. Hum. Genet. 2011, 56:423-427.
30. Shaiq P.A., Stuart P.E., Latif A., Schmotzer C., Kazmi A.H., Khan M.S., Azam M., Tejasvi T., Voorhees J.J., Raja G.K., Elder J.T., Qamar R., Nair R.P. Genetic associations of psoriasis in a Pakistani population. Br. J. Dermatol. 2013, 169:406-411.